表紙
市場調查報告書

抗真菌藥物的全球市場預測:Azole、Echinocandins、Polyenes、丙烯基胺、Voriconazole、Posaconazole (2019∼2029年)

Global Antifungal Drugs Market Forecast 2019-2029: Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Others

出版商 Visiongain Ltd 商品編碼 904772
出版日期 內容資訊 英文 203 Pages
商品交期: 最快1-2個工作天內
價格
抗真菌藥物的全球市場預測:Azole、Echinocandins、Polyenes、丙烯基胺、Voriconazole、Posaconazole (2019∼2029年) Global Antifungal Drugs Market Forecast 2019-2029: Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Others
出版日期: 2019年06月04日內容資訊: 英文 203 Pages
簡介

全球抗真菌藥物市場預測將在2018年達到140億美元,在預測期間中預測將以3.8%的年複合成長率 (CAGR) 擴大。

本報告提供全球抗真菌藥物市場相關分析,市場基本結構,主要的推動及阻礙市場要素,市場規模、佔有率趨勢預測,各地區/主要國家市場詳細趨勢,及主要企業的簡介等系統性資訊。

第1章 調查概要

第2章 簡介:抗真菌藥物

  • 抗真菌藥物是什麼?
  • 抗真菌藥物療法的演進
  • 抗真菌藥物的區分
  • 一般的侵入性真菌症
  • 現在,可利用的抗真菌藥物
  • 市場動態

第3章 抗真菌藥物市場

  • 全球抗真菌藥物市場:概要
  • 全球抗真菌藥物市場:成果
  • 全球抗真菌藥物市場:預測
  • 全球抗真菌藥物市場:各適應症的銷售額預測

第4章 主要抗真菌藥物

  • 全球抗真菌藥物市場
  • Azole
  • Echinocandins
  • Polyenes
  • 丙烯基胺

第5章 主要國家市場

  • 全球抗真菌藥物市場地區分析
  • 全球抗真菌藥物市場:地區預測

第6章 北美的抗真菌藥物市場

  • 美國市場:預測
  • 加拿大市場:趨勢、發展

第7章 歐洲的抗真菌藥物市場

  • 歐洲市場:各國市場佔有率轉變
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他

第8章 亞太地區的抗真菌藥物市場

  • 日本市場:趨勢、發展
  • 中國
  • 印度
  • 其他

第9章 南美的抗真菌藥物市場

  • 巴西
  • 墨西哥
  • 其他

第10章 中東、非洲的抗真菌藥物市場

  • 沙烏地阿拉伯
  • 南非
  • 其他

第11章 主要企業

  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Bayer AG
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Gilead Sciences, Inc.
  • Enzon Pharmaceuticals, Inc.
  • Kramer Laboratories, Inc.

第12章 研發產品線

第13章 結論

目錄
Product Code: PHA0425

The global antifungal drugs market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period. In 2018, the global antifungal drugs market was dominated by Azoles.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 203-page report you will receive 85 tables and 101 figures - all unavailable elsewhere.

The 203-page report provides clear detailed insight into the antifungal drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Antifungal Drugs Market forecasts from 2019-2029
  • Global Antifungal Drugs Market forecasts from 2019-2029 by Segment :
  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Others
  • Global Antifungal Drugs Market forecasts from 2019-2029 by Indication :
  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Others
  • Global Antifungal Drugs Market forecasts from 2019-2029 by Drugs :
  • Voriconazole
  • Posaconazole
  • Clotrimazole
  • Isavuconazole
  • Fluconazole
  • Caspofungin
  • Micagunfin
  • Amphotericin
  • Lamisil
  • Global Antifungal Drugs Market forecasts from 2019-2029 by regional and national market :
  • North America : The U.S., Canada
  • Europe : Germany, France, the UK, Italy, Spain, Rest of Europe
  • Asia-Pacific : Japan, China, India, Rest of APAC
  • Latin America : Brazil, Mexico, Rest of Latin America

image1

Each regional market is further segmented into Azoles, Echinocandins, Polyenes, Allylamines, Dermatophytosis, Aspergillosis, Candidiasis, Others

  • Profiles of the selected leading companies :
  • Abbott Laboratories
  • Bayer AG
  • Enzon Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • Kramer Laboratories, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer
  • Sanofi S.A.
  • Antifungal Drugs R&D Pipeline
  • Key Questions Answered by this Report:
  • How is the Antifungal Drugs market evolving?
  • How will each Antifungal Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
  • How will the market shares for each Antifungal Drugs submarket develop from 2019 to 2029?
  • Will leading national Antifungal Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
  • Who are the leading players?
  • How will the industry evolve during the period between 2019 and 2029?

Table of Contents

1. Report Overview

  • 1.1 Global Antifungal Drugs Market Overview
  • 1.2 Overview of Findings
  • 1.3 Structure of the Report
  • 1.4 Global Antifungal Drugs Market Segmentation
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8. Who is This Report For?
  • 1.9 Methodology
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to Antifungal Drugs

  • 2.1. What are Antifungal Drugs?
  • 2.2. The Evolution of Antifungal Drug Therapy?
    • 2.2.1 History of antifungal therapy
    • 2.2.2. Clinical Indications
  • 2.3. Antifungal Drugs Segmentation
    • 2.3.1 Azoles
      • 2.3.1.1 Overview of Clinical Uses:
      • 2.3.1.2. Indication Insights
    • 2.3.2. Echinocandins
      • 2.3.2.1 Echinocandins and Relevance in Biofilms
    • 2.3.3 Polyenes
    • 2.3.4. Allylamines
  • 2.4. Common Invasive Fungal Diseases
  • 2.5. Currently available antifungal drugs
  • 2.6. Market Dynamics
    • 2.6.1 Drivers
      • 2.6.1.1. Increasing incidence of fungal infections
      • 2.6.1.2. Increase in awareness
    • 2.6.2. Restraint
      • 2.6.2.1 Increasing resistance to antifungal drugs

3. Antifungal Drugs Market, 2019-2029

  • 3.1 Global Antifungal Drugs: Market Overview
    • 3.1.1 Segments within the Global Antifungal Drugs Market
  • 3.2 The Global Antifungal Drugs Market in 2017 and 2018
  • 3.3 Global Antifungal Drugs: Market Forecast 2019-2029
    • 3.3.1 Market Sectors That Will Drive Antifungal Drugs Growth
    • 3.3.2 Global Antifungal Drugs Market - Changing Market Shares by Sector 2019-2029
  • 3.4 Global Antifungal Drugs Market by Indication: Sales Forecast 2019-2029
    • 3.4.1 Global Antifungal Drugs Market - Changing Market Shares by Sector 2019-2029

4. Leading Drugs in the Antifungal Drugs Market 2019-2029

  • 4.1 The Global Antifungal Drugs Market in 2017 and 2018
  • 4.2 Azoles
    • 4.2.1. Voriconazole (Vfend)
    • 4.2.2 Voriconazole (Vfend): Sales Forecast 2019-2029
    • 4.2.3 Posaconazole (Noxafil)
    • 4.2.4 Posaconazole (Noxafil): Sales Forecast 2019-2029
    • 4.2.5. Clotrimazole (Canesten)
    • 4.2.6. Clotrimazole (Canesten): Sales Forecast 2019-2029
    • 4.2.7. Isavuconazole (CRESEMBA)
    • 4.2.8. Isavuconazole (CRESEMBA): Sales Forecast 2019-2029
    • 4.2.9. Fluconazole (Diflucan)
    • 4.2.10. Fluconazole (Diflucan): Sales Forecast 2019-2029
  • 4.3 Echinocandins
    • 4.3.1. Caspofungin (Cancidas)
    • 4.3.2. Caspofungin (Cancidas): Sales Forecast 2019-2029
    • 4.3.3. Micafungin (Mycamine/ Funguard)
    • 4.3.4. Micafungin (Mycamine/ Funguard): Sales Forecast 2019-2029
  • 4.4 Polyenes
    • 4.4.1. AmBisome (Gilead Sciences)
    • 4.4.2 AmBisome: Sales Forecast 2019-2029
  • 4.5 Allylamines
    • 4.5.1. Lamisil (terbinafine) - Novartis
      • 4.5.1.1 Lamisil Patent Expiry
      • 4.5.1.2 Lamisil Sales Affected by Novartis Manufacturing Problems
      • 4.5.1.3. Lamisil: Sales Forecast 2019-2029

5. Leading National Markets 2019-2029

  • 5.1. Geographical Breakdown of the World Antifungal Drugs Market
  • 5.2 World Antifungal Drugs Market: Regional Forecast 2019-2029
    • 5.2.1 How Will Regional Market Shares Change to 2029?

6. North America Antifungal Drugs Market 2019-2029

  • 6.1. US Antifungal Drugs Market: Market Forecast 2019-2029
  • 6.2. Canada Antifungal Drugs Market: Trends and Developments

7. Europe Antifungal Drugs Market 2019-2029

  • 7.1 Europe Markets: Changing Market Shares by Country, 2019-2029
  • 7.2 Germany
    • 7.2.1 German Antifungal Drugs Market: Market Forecast 2019-2029
  • 7.3. France Antifungal Drugs Market Forecast 2019-2029
  • 7.4. U.K.
    • 7.4.1. U.K. Antifungal Drugs Market Forecast 2019-2029
  • 7.5 Italy
    • 7.5.1 Italy Antifungal Drugs Market Forecast 2019-2029
  • 7.6. Spain Antifungal Drugs Market Forecast 2019-2029
  • 7.7. Rest of Europe Antifungal Drugs Market Forecast 2019-2029

8. Asia-Pacific Antifungal Drugs Market 2019-2029

  • 8.1. Japan Antifungal Drugs Market: Trends and Developments
    • 8.1.1 Japanese Antifungal Drugs Market Forecast 2019-2029
  • 8.2 China
    • 8.2.1 Chinese Antifungal Drugs Market Forecast 2019-2029
  • 8.3. India
    • 8.3.1 Indian Antifungal Drugs Market Forecast 2019-2029
  • 8.4. Rest of Asia-Pacific Antifungal Drugs Market: Trends and Developments

9. Latin America Antifungal Drugs Market 2019-2029

  • 9.1 Brazil: Focus on Domestic Drug Manufacturing
    • 9.1.1 Brazil Antifungal Drugs Market Forecast 2019-2029
  • 9.2. Mexico Antifungal Drugs Market: Trends and Developments
  • 9.3. Rest of Latin America Antifungal Drugs Market: Trends and Developments

10. Middle East & Africa Antifungal Drugs Market 2019-2029

  • 10.1. Saudi Arabia Antifungal Drugs Market Forecast 2019-2029
  • 10.2. South Africa Antifungal Drugs Market Forecast 2019-2029
  • 10.3. Rest of Middle East & Africa Antifungal Drugs Market Forecast 2019-2029

11. Leading Companies in the Antifungal Drugs Market, 2019

  • 11.1 Novartis AG
    • 11.1.1 Novartis: Antifungal Drugs Product Portfolio
    • 11.1.2 Novartis AG: Financial Overview
    • 11.1.3 Novartis AG: Recent Transactions Summary
  • 11.2. Pfizer, Inc.
    • 11.2.1 Pfizer, Inc.: Antifungal Drugs Portfolio
    • 11.2.2 Pfizer, Inc.: Financial Overview
    • 11.2.3 Pfizer, Inc.: Recent Developments
  • 11.3. Sanofi S.A.
    • 11.3.1 Sanofi S.A.: Antifungal Drugs Portfolio
    • 11.3.2 Sanofi S.A.: Financial Overview
    • 11.3.3 Sanofi S.A.: Recent Developments
  • 11.4. GlaxoSmithKline plc
    • 11.4.1 GlaxoSmithKline plc: Antifungal Drugs Portfolio
    • 11.4.2 GlaxoSmithKline plc: Financial Overview
    • 11.4.3 GlaxoSmithKline plc: Recent Transactions Summary
  • 11.5. Bayer AG
    • 11.5.1 Bayer AG: Antifungal Drugs Portfolio
    • 11.5.2 Bayer AG: Financial Overview
    • 11.5.3 Bayer AG: Recent Transactions Summary
  • 11.6. Merck & Co., Inc.
    • 11.6.1 Merck & Co., Inc.: Antifungal Drugs Portfolio
    • 11.6.2 Merck & Co., Inc.: Financial Overview
    • 11.6.3 Merck & Co., Inc.: Recent Transactions Summary
  • 11.7. Abbott Laboratories
    • 11.7.1 Abbott Laboratories: Antifungal Drugs Product Portfolio
    • 11.7.2 Financial Overview
    • 11.7.3 Recent Transactions Summary
  • 11.8. Gilead Sciences, Inc.
    • 11.8.1 Gilead Sciences, Inc.: Antifungal Drugs Product Portfolio
    • 11.8.2 Financial Overview
    • 11.8.3 Recent Transactions Summary
  • 11.9. Enzon Pharmaceuticals, Inc.
    • 11.9.1 Enzon Pharmaceuticals, Inc.:Antifungal Drugs Product Portfolio
    • 11.9.2 Financial Overview
  • 11.10. Kramer Laboratories, Inc.
    • 11.10.1 Kramer Laboratories, Inc.: Antifungal Drugs Product Portfolio
    • 11.10.2 Recent Transactions Summary

12. Antifungal Drugs R&D Pipeline 2018

  • 12.1. Antifungal drug development considerations
  • 12.2. The antifungal pipeline

13. Conclusions

  • 13.1 The World Antifungal Drugs Market in 2017 and 2018
    • 13.1.1 Current Leading Antifungal Drugs Segments
    • 13.1.2 Leading Regional Markets
  • 13.2 World Antifungal Drugs Market Forecast 2019-2029
  • 13.3 The Future of the Antifungal Drugs Market?

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Tables

  • Table 2.1 Classification of Anti-Fungal Agents
  • Table 2.1 Azoles as Antifungal Agents
  • Table 2.3 Toxicity OF Azoles
  • Table 2.4 Common Invasive Fungal Diseases
  • Table 3.1 The Global Antifungal Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017 and 2018
  • Table 3.2 Global Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 3.3 Global Antifungal Drugs Market by Sector: CAGR (%), 2019-2023, 2023-2029, 2019-2029
  • Table 3.4 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029
  • Table 3.5 Global Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 3.6 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029
  • Table 4.1 The Global Antifungal Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017 and 2018
  • Table 4.2 Global Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.3 Global Azoles Market Forecast: Revenues ($m) AGR (%), AGR (%), 2019-2029
  • Table 4.4 Voriconazole (Vfend) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.5 Posaconazole (Noxafil) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.6 Clotrimazole (Canesten) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.7 Isavuconazole (CRESEMBA) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.8 Fluconazole (Diflucan) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.9 Global Echinocandins Market Forecast: Revenues ($m), AGR (%), AGR (%), 2019-2029
  • Table 4.10 Caspofungin (Cancidas) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.11 Micafungin (Mycamine/ Funguard) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.12 Global Polyenes Market Forecast: Revenues ($m) AGR (%), AGR (%), 2019-2029
  • Table 4.13 AmBisome Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 4.14 Global Allylamines Market Forecast: Revenues ($m), AGR (%), AGR (%), 2019-2029
  • Table 4.15 Lamisil Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 5.1 Global Antifungal Drugs Market by Region: Revenue ($m), 2017 and 2018
  • Table 5.2 Global Antifungal Drugs Market Forecast by Region: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 5.3 Global Antifungal Drugs Market by Region: CAGR (%), 2019-2023, 2023-2029, 2019-2029
  • Table 5.4 Global Antifungal Drugs Market by Region: CAGR (%), 2019-2023, 2023-2029, 2019-2029
  • Table 6.1 North America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 6.2 North America Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 6.3 North America Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 6.4 U.S. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 6.5 Canada Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 7.1 Europe Antifungal Drugs Market by Country/Sub-region: Revenue ($m) and Market Share (%), 2017
  • Table 7.2 Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 7.3 Global Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 7.4 Europe Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 7.5 Europe Antifungal Drugs Market by Country/Sub-region: CAGR (%), 2019-2023, 2023-2029, 2019-2029
  • Table 7.6 Germany Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
  • Table 7.7 France Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 7.8 U.K. Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 7.9 Italy Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
  • Table 7.10 Spain Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
  • Table 7.11 Rest of Europe Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029
  • Table 8.1 Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.2 Asia-Pacific Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 8.3 Asia-Pacific Antifungal Drugs Market Forecast by Country: Revenues ($ m), AGR (%), CAGR (%), 2019-2029
  • Table 8.4 Japan Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 8.5 China Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 8.6 India Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 8.7 Rest of Asia-Pacific Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 9.1 Latin America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 9.2 Latin America Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 9.3 Latin America Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 9.4 Brazil Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 9.5 Mexico Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 9.6 Rest of Latin America Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 10.1 Middle East and Africa Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2019-2029
  • Table 10.2 Middle East & Africa Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 10.3 Middle East & Africa (MEA) Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029
  • Table 10.4 Saudi Arabia Antifungal Drugs Market Forecast by Country: Revenues ($ m), AGR (%), CAGR (%), 2019-2029
  • Table 10.5 South Africa Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029
  • Table 10.6 Rest of MEA Antifungal Drugs Market Forecast; ($m, AGR%, CAGR%), 2019-2029
  • Table 11.1 Novartis AG: Overview
  • Table 11.2 Novartis AG: Revenue ($m), AGR (%), 2014-2018
  • Table 11.3 Pfizer, Inc.: Overview
  • Table 11.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Table 11.5 Sanofi S.A.: Overview
  • Table 11.6 Sanofi S.A.: Revenue ($m), AGR (%), 2014-2018
  • Table 11.7 GlaxoSmithKline plc: Overview
  • Table 11.8 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2014-2018
  • Table 11.9 Bayer AG: Overview
  • Table 11.10 Bayer AG: Revenue ($m), AGR (%), 2014-2018
  • Table 11.11 Merck & Co., Inc.: Overview
  • Table 11.12 Merck & Co., Inc.: Revenue ($m), AGR (%), 2014-2018
  • Table 11.13 Abbott Laboratories: Overview
  • Table 11.14 Abbott Laboratories: Revenue ($m), AGR (%), 2014-2018
  • Table 11.15 Gilead Sciences, Inc.: Overview
  • Table 11.16 Gilead Sciences, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Table 11.17 Enzon Pharmaceuticals, Inc.: Overview, 2019
  • Table 11.18 Enzon Pharmaceuticals, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Table 11.19 Kramer Laboratories, Inc.: Overview
  • Table 12.1 Pipeline R&D Products, 2018
  • Table 12.2 Pipeline R&D Products, 2018

List of Figures

  • Figure 1.1 Global Antifungal Drugs Market Segmentation Overview
  • Figure 2.1 Common invasive fungal diseases
  • Figure 3.1 The Global Antifungal Drugs Market Forecast by Sector: Revenue ($m), 2017 and 2018
  • Figure 3.2 The Global Antifungal Drugs Market Forecast: Revenue ($m), 2017 and 2018
  • Figure 3.3 Global Antifungal Drugs Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 3.4 The Global Antifungal Drugs Market Forecast: CAGR (%) by Sector, 2019-2023
  • Figure 3.5 The Global Antifungal Drugs Market Forecast: CAGR (%) by Sector, 2023-2029
  • Figure 3.6 The Global Antifungal Drugs Market Forecast: CAGR (%) by Sector, 2019-2029
  • Figure 3.7 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029
  • Figure 3.8 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2018
  • Figure 3.9 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2023
  • Figure 3.10 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2029
  • Figure 3.11 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029
  • Figure 3.12 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2018
  • Figure 3.13 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2023
  • Figure 3.14 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2029
  • Figure 4.1 The Global Antifungal Drugs Market Forecast by Sector: Revenue ($m), 2017 and 2018
  • Figure 4.2 Global Azoles Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 4.3 Global Voriconazole (Vfend) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.4 Global Posaconazole (Noxafil) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.5 Global Clotrimazole (Canesten) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.6 Global Isavuconazole (CRESEMBA) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.7 Global Fluconazole (Diflucan) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.8 Global Echinocandins Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 4.9 Global Caspofungin (Cancidas) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.10 Global Micafungin (Mycamine/ Funguard) Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.11 Global Polyenes Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 4.12 Global AmBisome Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.13 Global Allylamines Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 4.14 Global Lamisil Market Forecast: Revenue ($m) and AGR (%), 2019-2029
  • Figure 5.1 World Antifungal Drugs Market: Revenues ($m) by Region, 2017
  • Figure 5.2 World Antifungal Drugs Market: Revenues ($m) by Region, 2018
  • Figure 5.3 Global Antifungal Drugs Market Forecast: Revenue ($m), AGR (%), 2019-2029
  • Figure 5.4 World Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018
  • Figure 5.5 World Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023
  • Figure 5.6 World Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029
  • Figure 6.1 North America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 6.2 North America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018
  • Figure 6.3 North America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023
  • Figure 6.4 North America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029
  • Figure 6.5 U.S. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 6.6 Canada Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 7.1 Europe Antifungal Drugs Market: Revenues ($m) by Country/Sub-region, 2017
  • Figure 7.2 Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 7.3 Europe Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018
  • Figure 7.4 Europe Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023
  • Figure 7.5 Europe Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029
  • Figure 7.6 Germany Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 7.7 France Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 7.8 U.K. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 7.9 Italy Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 7.10 Spain Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029
  • Figure 7.11 Rest of Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.1 Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.2 Asia-Pacific Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018
  • Figure 8.3 Asia-Pacific Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023
  • Figure 8.4 Asia-Pacific Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029
  • Figure 8.5 Japan Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2017-2029
  • Figure 8.6 China Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2017-2029
  • Figure 8.7 India Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 8.8 Rest of Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 9.1 Latin America Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029
  • Figure 9.2 Latin America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018
  • Figure 9.3 Latin America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023
  • Figure 9.4 Latin America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029
  • Figure 9.5 Brazil Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 9.6 Mexico Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 9.7 Rest of Latin America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 10.1 Middle East & Africa (MEA) Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029
  • Figure 10.2 Middle East & Africa Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018
  • Figure 10.3 Middle East & Africa Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023
  • Figure 10.4 Middle East & Africa Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029
  • Figure 10.5 Saudi Arabia Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029
  • Figure 10.6 South Africa Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029
  • Figure 10.7 Rest of MEA Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2017-2029
  • Figure 11.1 Novartis AG: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.2 Novartis AG: Business Segment Revenue Share (%), 2018
  • Figure 11.3 Novartis AG by Region Revenue Share (%), 2018
  • Figure 11.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.5 Pfizer, Inc.: Business Segment Revenue Share (%), 2018
  • Figure 11.6 Pfizer, Inc.: National Revenue Share (%), 2018
  • Figure 11.7 Sanofi S.A.: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.8 Sanofi S.A.: Revenue by Region Share (%), 2018
  • Figure 11.9 Sanofi S.A.: Revenue by Segment Share (%), 2018
  • Figure 11.10 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.11 GlaxoSmithKline plc: Business Segment Revenue Share (%), 2018
  • Figure 11.12 GlaxoSmithKline plc: Region Revenue Share (%), 2018
  • Figure 11.13 Bayer AG: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.14 Bayer AG: Business Segment Revenue Share (%), 2018
  • Figure 11.15 Bayer AG: Region Revenue Share (%), 2018
  • Figure 11.16 Merck & Co., Inc.: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.17 Merck & Co., Inc.: Business Segment Revenue Share (%), 2018
  • Figure 11.18 Merck & Co., Inc.: Region Revenue Share (%), 2018
  • Figure 11.19 Abbott Laboratories: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.20 Abbott Laboratories: Business Segment Revenue Share (%), 2018
  • Figure 11.21 Abbott Laboratories: Region Revenue Share (%), 2018
  • Figure 11.22 Gilead Sciences, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Figure 11.23 Gilead Sciences, Inc.: Region Revenue Share (%), 2018
  • Figure 11.24 Enzon Pharmaceuticals, Inc.: Revenue ($m), AGR (%), 2014-2018
  • Figure 13.1 Global Antifungal Drugs Market by Product Type: Market Share (%), 2018
  • Figure 13.2 Antifungal Drugs Market by Region Share (%), 2017, 2023, 2029

Companies Listed

  • Abbott Laboratories
  • Alcon
  • Alere
  • Amber Luong
  • AMLadeed
  • Amplyx Pharmaceuticals
  • Anacor
  • Arno Therapeutics
  • Astellas Pharma
  • AstraZeneca
  • Avista Capital Partners
  • Basilea Pharmaceutica Ltd.
  • Bayer AG
  • Bioverativ Inc.
  • Bumrungrad
  • Celltrion
  • Cleveland Clinic
  • Dana Holdings
  • Eisai
  • Enzon Pharmaceuticals, Inc.
  • Fondazione Telethon (Telethon)
  • Gilead Sciences
  • GlaxoSmithKline plc
  • Hospira
  • Janssen
  • Kramer Laboratories, Inc.
  • LEO Pharma
  • Merck & Co., Inc.
  • Mirati Therapeutics
  • Nizoral
  • Novartis AG
  • Novo Nordisk
  • Ortho-McNeil
  • Ospedale San Raffaele (OSR)
  • Pfizer Inc.
  • PowerVision, Inc.,
  • Regeneron Pharmaceuticals, Inc.
  • Sandoz Pharmaceuticals
  • Sanofi Pasteur
  • Sanofi S.A.
  • Shaman Pharmaceuticals
  • Solvay Pharmaceuticals
  • Tokuyama Corporation
  • Trius
  • Vamed
  • Vical Incorporated

List of Organisations Mentioned in The Report

  • Agência Nacional de Vigilância Sanitária
  • American Depositary Receipts
  • Antimicrobial Resistance Centre in England
  • Assiut University
  • Boston University School of Law
  • Centers of Disease Control and Prevention (CDC)
  • Clinical and Laboratory Standards Institute
  • Department of Infectious Diseases and Medical Microbiology
  • European Commission
  • European Economic Area
  • European Medicines Agency (EMA)
  • European Organisation for Research and Treatment of Cancer - EORTC
  • European Society of Clinical Microbiology and Infectious Diseases
  • European Union
  • Food and Drug Administration (FDA)
  • Future Science Group
  • German Society of Haematology and Oncology
  • Global Action Fund for Fungal Infections
  • Government of Abu Dhabi
  • Infectious Diseases Society of America
  • Institut für Demoskopie Allensbach (IfD)
  • Johns Hopkins
  • Maisonneuve-Rosemont Hospital Research Center
  • Ministry of Health Italy
  • Ministry of Health, Labor and Welfare (MHLW)
  • National Center for Biotechnology Information
  • National Institute on Aging
  • National Treasury of Republic of South Africa
  • Novartis Institutes for BioMedical Research (NIBR)
  • SENTRY program
  • Servizio Sanitario Nazionale
  • Sistema Ünico de Saúde
  • Sociedade Brasileira de Infectologia
  • The University of Texas Health Science Center, Houston
  • U.S. Department of Health and Human Services
  • Université de Montréal, Montréal, Canada
  • University of Arizona